|Grant Affiliation:||Third party request|
|Strategy:||Combo: DNA & protein vaccines|
|Study Type:||Phase I|
|Study Start Date:||2015-03-18|
|Study Made Public:||NA|
A phase I double blind placebo-controlled clinical trial to evaluate the safety and immunogenicity of the combination of DNA-HIV-PT123 and AIDSVAX B/E in HIV-1 uninfected adult participants with or without underlying Schistosoma mansoni infection
CAVD 653 (EV06/TP026) is a clinical trial investigating the impact of the S. mansoni infection on HIV vaccine safety and immune responses.
Sign in to see full information about this study and to download study data.